BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19273789)

  • 1. Glaucoma monitoring in a clinical setting: glaucoma progression analysis vs nonparametric progression analysis in the Groningen Longitudinal Glaucoma Study.
    Wesselink C; Heeg GP; Jansonius NM
    Arch Ophthalmol; 2009 Mar; 127(3):270-4. PubMed ID: 19273789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for visual field progression in the groningen longitudinal glaucoma study: a comparison of different statistical approaches.
    Wesselink C; Marcus MW; Jansonius NM
    J Glaucoma; 2012 Dec; 21(9):579-85. PubMed ID: 21701396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of focal lamina cribrosa defect on glaucomatous visual field progression.
    Faridi OS; Park SC; Kabadi R; Su D; De Moraes CG; Liebmann JM; Ritch R
    Ophthalmology; 2014 Aug; 121(8):1524-30. PubMed ID: 24697910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage.
    Prata TS; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
    Ophthalmology; 2010 Jan; 117(1):24-9. PubMed ID: 19896197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global and pointwise rates of decay in glaucoma eyes deteriorating according to pointwise event analysis.
    Nassiri N; Moghimi S; Coleman AL; Law SK; Caprioli J; Nouri-Mahdavi K
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1208-13. PubMed ID: 23329667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glaucoma progression detection with frequency doubling technology (FDT) compared to standard automated perimetry (SAP) in the Groningen Longitudinal Glaucoma Study.
    Wesselink C; Jansonius NM
    Ophthalmic Physiol Opt; 2017 Sep; 37(5):594-601. PubMed ID: 28836391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency-doubling technology perimetry for detection of the development of visual field defects in glaucoma suspect eyes: a prospective study.
    Liu S; Yu M; Weinreb RN; Lai G; Lam DS; Leung CK
    JAMA Ophthalmol; 2014 Jan; 132(1):77-83. PubMed ID: 24177945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
    Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
    Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of standard automated perimetry, frequency-doubling technology perimetry, and short-wavelength automated perimetry for detection of glaucoma.
    Liu S; Lam S; Weinreb RN; Ye C; Cheung CY; Lai G; Lam DS; Leung CK
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7325-31. PubMed ID: 21810975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: patterns of retinal nerve fiber layer progression.
    Leung CK; Yu M; Weinreb RN; Lai G; Xu G; Lam DS
    Ophthalmology; 2012 Sep; 119(9):1858-66. PubMed ID: 22677426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma population.
    Casas-Llera P; Rebolleda G; Muñoz-Negrete FJ; Arnalich-Montiel F; Pérez-López M; Fernández-Buenaga R
    Br J Ophthalmol; 2009 Dec; 93(12):1576-9. PubMed ID: 19535357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification and Predictors of Visual Field Variability in Healthy, Glaucoma Suspect, and Glaucomatous Eyes Using SITA-Faster.
    Tan JCK; Agar A; Kalloniatis M; Phu J
    Ophthalmology; 2024 Jun; 131(6):658-666. PubMed ID: 38110124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scanning laser polarimetry of the retinal nerve fiber layer in perimetrically unaffected eyes of glaucoma patients.
    Reus NJ; Lemij HG
    Ophthalmology; 2004 Dec; 111(12):2199-203. PubMed ID: 15582074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.
    Kim J; Dally LG; Ederer F; Gaasterland DE; VanVeldhuisen PC; Blackwell B; Sullivan EK; Prum B; Shafranov G; Beck A; Spaeth GL;
    Ophthalmology; 2004 Nov; 111(11):2109-16. PubMed ID: 15522379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma with early visual field loss affecting both hemifields and the risk of disease progression.
    De Moraes CG; Prata TS; Tello C; Ritch R; Liebmann JM
    Arch Ophthalmol; 2009 Sep; 127(9):1129-34. PubMed ID: 19752421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual field progression in glaucoma: total versus pattern deviation analyses.
    Artes PH; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4600-6. PubMed ID: 16303955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the visual field index in glaucoma patients with moderately advanced visual field loss.
    Lee JM; Cirineo N; Ramanathan M; Nouri-Mahdavi K; Morales E; Coleman AL; Caprioli J
    Am J Ophthalmol; 2014 Jan; 157(1):39-43. PubMed ID: 24200229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Quality and Output of Different Optimal Perimetric Testing Approaches in Children With Glaucoma.
    Patel DE; Cumberland PM; Walters BC; Russell-Eggitt I; Brookes J; Papadopoulos M; Khaw PT; Viswanathan AC; Garway-Heath D; Cortina-Borja M; Rahi JS;
    JAMA Ophthalmol; 2018 Feb; 136(2):155-161. PubMed ID: 29285534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic disc progression and rates of visual field change in treated glaucoma.
    De Moraes CG; Liebmann JM; Park SC; Teng CC; Nemiroff J; Tello C; Ritch R
    Acta Ophthalmol; 2013 Mar; 91(2):e86-91. PubMed ID: 23356423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for visual field progression in treated glaucoma.
    De Moraes CG; Juthani VJ; Liebmann JM; Teng CC; Tello C; Susanna R; Ritch R
    Arch Ophthalmol; 2011 May; 129(5):562-8. PubMed ID: 21555607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.